Newsroom
Sorted by: Latest
-
Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today presented late-breaking data from its MOMENTUM trial examining the prevalence of endogenous hypercortisolism in patients with resistant hypertension at the 2026 American College of Cardiology...
-
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis
ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. Atopic dermatitis is the most common inflammatory skin diso...
-
Anumana Secures FDA Clearance for First-of-Its-Kind ECG-AI Algorithm for Early Detection of Pulmonary Hypertension
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm....
-
Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology’s 75th Annual Scientific Session and Expo
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced long-term efficacy and safety data from a two-year long open-label extension (OLE) study of investigational plozasiran supporting its potential as therapeutic solution for a diverse spectrum of patients with hypertriglyceridemia (HTG). The data were presented by Dr. Christie M. Ballantyne, MD, professor at Baylor College of Medicine, member of the Texas Heart Institute at Baylor, and Principal Inve...
-
IBRX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that ImmunityBio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)--The case alleges ImmunityBio materially overstated Anktiva’s capabilities....
-
Visa, Street Soccer USA and Bank of America to Bring Visa Street Soccer Parks to Every FIFA World Cup 2026™ Host City in the U.S.
SAN FRANCISCO & CHARLOTTE, N.C.--(BUSINESS WIRE)--Visa, Street Soccer USA and Bank of America expand Visa Street Soccer Parks to every U.S. FIFA World Cup 2026™ Host City....
-
Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy™ (xanomeline and trospium chloride)
PRINCETON, N.J.--(BUSINESS WIRE)--Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy....
-
Nicklaus Companies LLC Closes Sale of Business to Jack Nicklaus-Backed 20 Majors, LLC
WEST PALM BEACH, Fla.--(BUSINESS WIRE)--Nicklaus Companies LLC (the “Company”), home to some of the most prestigious global brands in golf, and a worldwide leader in golf-course design, today announced that it has successfully closed on the sale of substantially all of its assets, including its licensing and design businesses, to 20 Majors, LLC (the “Buyer” or “20 Majors”), an investment group led by Jack Nicklaus. The sale followed a robust chapter 11 sale process, which culminated in an aucti...
-
METC截止日期:Rosen Law Firm敦促損失超過10萬美元的Ramaco Resources, Inc. (NASDAQ: METC)股東與法律事務所聯絡以瞭解有關其合法權益的資訊
紐約--(BUSINESS WIRE)--(美國商業資訊)-- 全球性投資人權益法律事務所Rosen Law Firm提醒投資人注意一項代表在2025年7月31日至2025年10月23日期間購買Ramaco Resources, Inc. (NASDAQ: METC)證券的投資人提起的集體訴訟。Ramaco自稱是一家「從事煤炭和稀土礦物的開採、開發和銷售」的公司。 如欲瞭解更多資訊,請遞交表格、向Phillip Kim律師寄送電子郵件,或致電866-767-3653聯絡我們。 指控內容:Rosen Law Firm正在調查對Ramaco Resources, Inc. (NASDAQ: METC)在其業務營運方面誤導投資人的指控。 起訴書指稱,在整個集體訴訟期內,被告做出了虛假和/或誤導性陳述且/或未揭露:(1)被告在破土動工後並未在Brook礦區展開任何實質性的開採活動;(2) Brook礦區未進行任何施工作業;(3)因此,Ramaco誇大了Brook礦區的開發進度;以及(4)由於上述原因,被告關於Ramaco的業務、營運和前景的正面陳述具有重大誤導性和/或缺乏合理依據。訴訟稱,當市...
-
METC截止日期:Rosen Law Firm敦促损失超过10万美元的Ramaco Resources, Inc. (NASDAQ: METC)股东与律所联系以了解有关其合法权益的信息
纽约--(BUSINESS WIRE)--(美国商业资讯)-- 全球性投资者权益律师事务所Rosen Law Firm提醒投资者注意一项代表在2025年7月31日至2025年10月23日期间购买Ramaco Resources, Inc. (NASDAQ: METC)证券的投资者提起的集体诉讼。Ramaco自称是一家“从事煤炭和稀土矿物的开采、开发和销售”的公司。 如需了解更多信息,请提交表格、向Phillip Kim律师发送电子邮件,或致电866-767-3653联系我们。 指控内容:Rosen Law Firm正在调查对Ramaco Resources, Inc. (NASDAQ: METC)在其业务运营方面误导投资者的指控。 起诉书指称,在整个集体诉讼期内,被告作出了虚假和/或误导性陈述且/或未披露:(1)被告在破土动工后并未在Brook矿区开展任何实质性的开采活动;(2) Brook矿区未进行任何施工作业;(3)因此,Ramaco夸大了Brook矿区的开发进度;以及(4)由于上述原因,被告关于Ramaco的业务、运营和前景的正面陈述具有重大误导性和/或缺乏合理依据。诉讼称,当市...